Bradley Saenger
2021
In 2021, Bradley Saenger earned a total compensation of $1.8M as Chief Financial Officer at Tonix Pharmaceuticals Holding, a 62% increase compared to previous year.
Compensation breakdown
| Bonus | $170,000 |
|---|---|
| Option Awards | $1,174,885 |
| Salary | $425,000 |
| Total | $1,769,885 |
Saenger received $1.2M in option awards, accounting for 66% of the total pay in 2021.
Saenger also received $170K in bonus and $425K in salary.
Rankings
In 2021, Bradley Saenger's compensation ranked 6,539th out of 12,415 executives tracked by ExecPay. In other words, Saenger earned more than 47.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,539 out of 12,415 | 47th |
Division Manufacturing | 2,812 out of 5,505 | 49th |
Major group Chemicals And Allied Products | 1,240 out of 2,375 | 48th |
Industry group Drugs | 1,105 out of 2,096 | 47th |
Industry Pharmaceutical Preparations | 802 out of 1,546 | 48th |
Source: SEC filing on March 18, 2022.
Saenger's colleagues
We found three more compensation records of executives who worked with Bradley Saenger at Tonix Pharmaceuticals Holding in 2021.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019